Validation of Hereditary Cancer Panel Testing

This white paper details the validation process of the CancerNext multigene panel test, which is designed to identify individuals with germline cancer predisposition. It outlines the importance of assay validation in ensuring the accuracy, reliability, and reproducibility of diagnostic tests, which are critical for patient safety and clinical decision-making. The paper emphasizes that validation is essential for meeting regulatory requirements and providing healthcare providers and patients with confidence in test results. It discusses the validation of genetic tests across diverse specimen and variant types, highlighting the need for consistent performance in various clinical scenarios. Additionally, the paper evaluates intra-assay repeatability and inter-assay reproducibility, which are crucial for assessing the assay's reliability. The document concludes by underscoring the significance of maintaining high-quality data throughout the genetic testing workflow to mitigate diagnostic errors and enhance patient care.